2020 Revenues ($USD) : $2,354,911,934 2020 Revenues (foreign currencies) : ₹174,600,000,000 2020 R&D spend : $152,988,351 2020 Number of Employees : 21,000 Fiscal Year End : 3/31/2020 Key People : K. Satish Reddy, chair
The late scientist and entrepreneur K. Anji Reddy started the Indian multinational in 1984 to make medicines accessible to everyone. The company's global generics business crossed the $1 billion mark in 2015. These days, the company offers more than 400 generic drugs and touts itself as one of the world's largest makers of active pharmaceuticals ingredients. The company is playing an important role in the fight against COVID-19 in India as it collaborates with the Russian Direct Investment Fund to conduct clinical trials and supply 100 million doses of Russia's Sputnik V vaccine to the South Asian giant. –CN
Dr. Reddy's facility in India. Image courtesy of Wikipedia.